Physician profile
Sean Mcmillan
NPI 1689885816
$1,831,092.81
in general payments reported to CMS, 2019-2025
48 companies · $228K in 2025
The $228K reported for 2025 was more than what 99% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $226K · 2020: $144K · 2021: $170K · 2022: $626K · 2023: $209K · 2024: $227K · 2025: $228K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $450K · Acquisitions: $112K · Honoraria: $40K · Travel and Lodging: $30K · Food and Beverage: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,330 · Entertainment: $46.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $449,531.87 |
| Acquisitions | $112,084.38 |
| Honoraria | $39,964.00 |
| Travel and Lodging | $30,264.46 |
| Food and Beverage | $14,534.64 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $14,100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,330.00 |
| Entertainment | $46.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $786,559.67 | 2022-2025 | Biobrace 23mm, Livatec Knee Preservation System, Linvatec Shoulder Arthroscopy |
| Davol INC. | $279,239.58 | 2019-2025 | Arista Ah Flexitip, Arista |
| Medical Device Business Services, INC. | $200,788.58 | 2019-2025 | Orthovisc, Peak, Healix Knotless Peek |
| Biorez, INC. | $99,739.83 | 2021-2022 | |
| Miach Orthopaedics, INC. | $87,136.06 | 2021-2025 | |
| Pacira Pharmaceuticals Incorporated | $68,010.98 | 2019-2025 | Iovera, Exparel, Zilretta |
| Trice Medical, INC. | $58,798.24 | 2019-2024 | |
| Anika Therapeutics, INC. | $52,415.44 | 2019-2025 | Tactoset, Ovomotion, Integrity Implant |
| Ethicon US, LLC | $30,531.73 | 2019-2021 | |
| Smith+Nephew, INC. | $25,756.19 | 2019-2023 | Pico 7, Renasys Go V2 Home |
| Arthrex, INC. | $25,755.94 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $18,602.06 | 2019-2025 | Comprehensive Shoulder System, Activbraid, Gel-One Cross-Linked Hyaluronate |
| Pristine Surgical LLC | $11,750.00 | 2024-2025 | Summit Arthroscope |
| Vericel Corporation | $11,093.86 | 2024 | Maci |
| Exactech, INC. | $10,629.24 | 2019 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $10,389.54 | 2019-2021 | |
| C. R. Bard, INC. & Subsidiaries | $7,500.00 | 2022 | |
| Ethicon INC. | $6,489.68 | 2020-2021 | |
| Prodigy Surgical Distribution, INC. | $5,909.62 | 2020-2025 | |
| Zurimed Technologies INC. | $5,492.36 | 2025 | Fiberlocker System |
| Eclipse Technology Solutions INC. | $5,247.35 | 2022-2025 | |
| Geistlich Pharma, North America, INC. | $4,244.87 | 2023-2024 | Bio-Gide, Geistlich Bio-Gide, Bio-Materials |
| Ossio INC | $3,230.38 | 2023-2024 | |
| Arcuro Medical INC | $2,500.00 | 2024 | Superball |
| Pacira Therapeutics, INC. | $2,348.36 | 2019-2021 | |
| Liberty Surgical INC. | $2,109.89 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $2,023.72 | 2021 | |
| Stryker Corporation | $2,008.27 | 2019-2025 | Mako, Triathlon, Insignia |
| Maruho Medical, INC. | $1,700.00 | 2020-2021 | |
| Depuy Synthes Sales INC. | $1,252.56 | 2019-2025 | Na, Dynacord, Monovisc |
| Becton, Dickinson and Company | $437.86 | 2019-2024 | Arista Ah Flexitip |
| Integrity Orthopaedics, INC. | $293.06 | 2024-2025 | Integrity Orthopaedics |
| Paladin Technology Solutions | $278.92 | 2022 | |
| Organogenesis INC. | $251.44 | 2020 | |
| Bard Access Systems, INC. | $91.95 | 2019 | |
| Brixton Biosciences, INC. | $90.00 | 2025 | Neural Ice |
| Novo Nordisk INC | $86.66 | 2022-2025 | |
| Bioventus LLC | $74.91 | 2019-2020 | |
| Innocoll Pharmaceuticals Limited | $57.55 | 2022-2023 | Posimir |
| Lundbeck LLC | $48.09 | 2023 | Rexulti |
| Ferring Pharmaceuticals INC. | $27.00 | 2019 | |
| Tenex Health INC. | $23.81 | 2021 | |
| Avanos Medical | $20.38 | 2023 | Trivisc Sodium Hyaluronate |
| Kowa Pharmaceuticals America, INC. | $17.00 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $13.79 | 2022 | |
| Shire North American Group INC | $13.33 | 2019 | |
| Horizon Therapeutics Plc | $13.06 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$83,100.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$1,531,572.74 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Mcmillan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.